Skip to main content

Table 3 EGFR mutation status of adenocarcinoma patients

From: Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

  N = 91 (%)
Not available 68 (75)
Tested 23 (25)
EGFR negative 15 (65)
Insufficient material 6 (26)
EGFR positive 2 (9)
  1. EGFR: Epidermal growth factor receptor.